Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Diagnostic accuracy and potential clinical role of muscle ultrasound in sarcopenia: An updated systematic review Acurácia diagnóstica e papel clínico potencial da ultrassonografia muscular na sarcopenia: Revisão sistemática atualizada Exactitud diagnóstica y posible papel clínico de la ecografía muscular en la sarcopenia: Revisión sistemática actualizada Received: 09/25/2026 | Accepted: 10/04/2026 | Published: 10/05/2026 Jean Baptiste Real Vrabic Junior ORCID: https://orcid.org/0009-0002-6437-3730 Faculdade Serra Dourada, Brazil E-mail: jeanjunior@faculdadeserradourada.com.br Clarissa Pereira Maciel ORCID: https://orcid.org/0009-0001-7660-6848 Faculdade Serra Dourada, Brazil E-mail: clarissa.maciel@faculdadeserradourada.com.br Davidson Bezerra da Silva ORCID: https://orcid.org/0000-0002-1193-0057 Faculdade Serra Dourada, Brazil E-mail: davidsonsilva@faculdadeserradourada.com.br João Felipe Silva Elache de Oliveira ORCID: https://orcid.org/0009-0008-6562-374X Faculdade Serra Dourada, Brazil E-mail: joaoelache@gmail.com Luiz Carlos Gonzaga Silva ORCID: https://orcid.org/0000-0001-6422-3068 Faculdade Serra Dourada, Brazil E-mail: luizgonzaga@faculdadeserradourada.com.br Carolina Alves Delpasso ORCID: https://orcid.org/0000-0002-4700-5883 CTE. Carbon Fit, Brazil E-mail: delpassoc@gmail.com David Ribeiro Costa ORCID: https://orcid.org/0000-0002-4188-1321 CTE. Carbon Fit, Brazil E-mail: profdavid8@gmail.com Abstract Objective: To evaluate the diagnostic accuracy of muscle ultrasound parameters for sarcopenia and determine whether this method can complement conventional assessment. Methods: A systematic review of diagnostic accuracy studies was conducted in accordance with PRISMA-DTA. PubMed/MEDLINE was searched, with supplementary searches in Europe PMC, Crossref, ClinicalTrials.gov, and study reference lists through September 17, 2026. Studies comparing quantitative ultrasound parameters with explicit diagnostic criteria for sarcopenia were included. Risk of bias was assessed using QUADAS-3. Results: Forty-five publications were included in the diagnostic accuracy synthesis. The rectus femoris was the most frequently investigated muscle, mainly through muscle thickness and cross-sectional area. Twelve studies provided verifiable 2 × 2 tables. In the three comparable studies of rectus femoris cross-sectional area, sensitivity ranged from 62.5% to 100% and specificity from 53.8% to 92.0%. Clinical and methodological heterogeneity precluded a valid meta-analysis. Of the 41 studies assessed with QUADAS-3, 38 had an overall high risk of bias. Conclusion: Muscle ultrasound may support screening and complement sarcopenia assessment, particularly because it is portable and suitable for bedside use. However, variation in protocols, muscles, diagnostic criteria, and cutoffs currently prevents its use as a replacement for conventional methods. Keywords: Sarcopenia; Ultrasonography; Sensitivity and Specificity; Diagnosis; Systematic Review. 1 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Resumo Objetivo: Avaliar a acurácia diagnóstica dos parâmetros de ultrassonografia muscular para sarcopenia e examinar se esse método pode complementar as formas convencionais de avaliação. Metodologia: Foi conduzida uma revisão sistemática de estudos de acurácia diagnóstica, de acordo com o PRISMA-DTA. As buscas foram realizadas no PubMed/MEDLINE e complementadas no Europe PMC, Crossref, ClinicalTrials.gov e nas referências dos estudos até 17 de setembro de 2026. Foram incluídas pesquisas que compararam parâmetros ultrassonográficos quantitativos com critérios diagnósticos explícitos para sarcopenia. O risco de viés foi avaliado pelo QUADAS-3. Resultados: Quarenta e cinco publicações compuseram a síntese de acurácia. O reto femoral foi o músculo mais investigado, principalmente por medidas de espessura e área de secção transversal. Doze estudos forneceram tabelas 2 × 2 verificáveis. Nos três estudos comparáveis sobre a área de secção transversal do reto femoral, a sensibilidade variou de 62,5% a 100% e a especificidade de 53,8% a 92,0%. A heterogeneidade clínica e metodológica impediu uma meta-análise válida. Entre os 41 estudos avaliados pelo QUADAS-3, 38 apresentaram alto risco global de viés. Conclusão: A ultrassonografia muscular pode contribuir para a triagem e complementar a avaliação da sarcopenia, sobretudo pela portabilidade e aplicação à beira-leito. Entretanto, a diversidade de protocolos, músculos, critérios diagnósticos e pontos de corte ainda impede sua utilização como substituta dos métodos convencionais. Palavras-chave: Sarcopenia; Ultrassonografia; Sensibilidade e Especificidade; Diagnóstico; Revisão Sistemática. Resumen Objetivo: Evaluar la exactitud diagnóstica de los parámetros de ecografía muscular para la sarcopenia y determinar si este método puede complementar la evaluación convencional. Metodología: Se realizó una revisión sistemática de estudios de exactitud diagnóstica de acuerdo con PRISMA-DTA. La búsqueda se efectuó en PubMed/MEDLINE y se complementó en Europe PMC, Crossref, ClinicalTrials.gov y las referencias de los estudios hasta el 17 de septiembre de 2026. Se incluyeron investigaciones que compararon parámetros ecográficos cuantitativos con criterios diagnósticos explícitos para sarcopenia. El riesgo de sesgo se evaluó mediante QUADAS-3. Resultados: Cuarenta y cinco publicaciones integraron la síntesis de exactitud. El recto femoral fue el músculo más investigado, principalmente mediante el grosor y el área de sección transversal. Doce estudios proporcionaron tablas 2 × 2 verificables. En los tres estudios comparables sobre el área de sección transversal del recto femoral, la sensibilidad varió del 62,5% al 100% y la especificidad del 53,8% al 92,0%. La heterogeneidad clínica y metodológica impidió realizar un metaanálisis válido. De los 41 estudios evaluados con QUADAS-3, 38 presentaron un alto riesgo global de sesgo. Conclusión: La ecografía muscular puede contribuir al cribado y complementar la evaluación de la sarcopenia, especialmente por su portabilidad y aplicación a pie de cama. Sin embargo, la diversidad de protocolos, músculos, criterios diagnósticos y puntos de corte todavía impide utilizarla como sustituta de los métodos convencionales. Palabras clave: Sarcopenia; Ultrasonografía; Sensibilidad y Especificidad; Diagnóstico; Revisión Sistemática. 1. Introduction Sarcopenia is a progressive and generalized muscle disease associated with aging and a range of clinical conditions. It increases the risk of falls, disability, hospitalization, and mortality. The revised European consensus (EWGSOP2) considers low muscle strength the primary indicator of the disease, confirms the diagnosis on the basis of low muscle quantity or quality, and uses physical performance to determine severity. AWGS 2019 follows a similar framework, with cutoffs adapted to Asian populations (Cruz-Jentoft et al., 2019; Chen et al., 2020). Conventional assessment combines tests of strength and physical performance with methods used to estimate muscle mass. Handgrip dynamometry, the chair stand test, and gait speed are simple clinical measures, whereas dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance analysis (BIA) are used to estimate muscle mass. Computed tomography and magnetic resonance imaging provide greater anatomical detail but are limited by cost, availability, the need to transport patients, and, in the case of computed tomography, exposure to ionizing radiation (Cruz-Jentoft et al., 2019; Chen et al., 2020). Muscle ultrasound has emerged as a portable, nonionizing alternative suitable for bedside use. B-mode ultrasound can provide measurements of muscle thickness, cross-sectional area, fascicle length, pennation angle, and echogenicity. These parameters represent different aspects of muscle quantity, architecture, and quality and can be assessed even in frail individuals or those with limited mobility (Nijholt et al., 2017; Perkisas et al., 2021). 2 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 The usefulness of these measurements, however, depends on examination standardization. Body position, anatomical site, transducer orientation and pressure, equipment settings, and the analytical method all influence the results. Age, sex, adiposity, edema, and hydration also affect the measurements, making it difficult to transfer cutoffs across populations and clinical settings (Nijholt et al., 2017; Perkisas et al., 2021; Fu et al., 2023). Previous reviews have reported promising diagnostic performance but combined studies that examined different muscles, parameters, and definitions of sarcopenia. Fu et al. (2023) found variable accuracy and a high risk of bias, whereas Yang et al. (2025) reported moderate-to-high performance for muscle-thickness measurements in older adults. Favorable findings have also been reported in chronic kidney disease, although hydration status and protocol diversity limit comparisons among studies (Yang et al., 2024). Since those reviews were published, further studies have investigated elastography, radiomics, composite models, and artificial intelligence tools. At the same time, it remains necessary to distinguish confirmed sarcopenia from isolated low muscle mass and to determine whether ultrasound adds information to conventional methods rather than merely being associated with them (Fu et al., 2023; Yik et al., 2024; Chen et al., 2025; Fu et al., 2025). This article aims to evaluate the diagnostic accuracy of muscle ultrasound parameters for sarcopenia and determine whether this method can complement conventional assessment. Secondary objectives were to examine the potential role of ultrasound as a screening, replacement, or complementary method and to assess the principal sources of heterogeneity and the methodological quality of the available evidence. 2. Methods 2.1 Study design and eligibility criteria A descriptive investigation was conducted (Risemberg et al., 2026a) using a quantitative approach regarding the number of articles selected to form the research corpus, and a qualitative approach regarding the discussions (Risemberg et al., 2026b; Pereira et al., 2018). A systematic review of diagnostic accuracy studies was conducted in accordance with PRISMA-DTA and, where applicable, PRISMA 2020 (McInnes et al., 2018; Page et al., 2021). The review question was structured according to the population, index test, target condition, reference standard, and accuracy outcomes. Primary studies in adults were included if they assessed quantitative muscle ultrasound parameters and compared them, in the same participants, with an explicit diagnostic criterion for sarcopenia. The primary population comprised people aged 60 years or older; studies of younger adults with conditions associated with sarcopenia were analyzed separately. Eligible index tests included muscle thickness, cross-sectional area, echo intensity, measures of muscle architecture, elastography, and models derived from these variables. Accepted reference standards were the EWGSOP, EWGSOP2, and AWGS consensus criteria or equivalent definitions that included an assessment of muscle mass. Studies without diagnostic classification, purely correlational investigations, case reports, reviews, protocols, and studies concerned exclusively with prognosis or treatment response were excluded. 2.2 Information sources and search strategy PubMed/MEDLINE was searched from database inception through September 17, 2026, without language restrictions. Controlled vocabulary and free-text terms related to sarcopenia, muscle loss, and ultrasonography were combined. 3 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Supplementary searches were conducted in Europe PMC, Crossref, and ClinicalTrials.gov, together with reference and citation tracking of relevant studies and reviews. The PubMed/MEDLINE search strategy was: ("Sarcopenia"[Mesh] OR sarcopen[tiab] OR myopeni[tiab] OR "muscle wasting"[tiab] OR "muscle loss"[tiab] OR "low muscle mass"[tiab]) AND ("Ultrasonography"[Mesh] OR "Elasticity Imaging Techniques"[Mesh] OR ultrasound[tiab] OR ultrasonograph[tiab] OR sonograph[tiab] OR echograph[tiab] OR "B-mode"[tiab] OR elastograph[tiab] OR sonoelastograph[tiab] OR "shear wave"[tiab] OR "shear-wave"[tiab] OR "acoustic radiation force impulse"[tiab] OR ARFI[tiab] OR "panoramic ultrasound"[tiab]) AND ("1900/01/01"[Date - Publication] : "2026/09/17"[Date - Publication]) 2.3 Study selection and data extraction Records were compiled in a standardized matrix, and duplicates were removed using PMID, DOI, and title verification. Titles and abstracts were screened first, followed by full-text assessment according to the eligibility criteria. Publications originating from the same cohort were linked to prevent double counting. The extracted data included authorship, year, country, study design, population, sample size, diagnostic criterion, method used to assess muscle mass, muscle examined, ultrasound protocol, parameter analyzed, cutoff, sensitivity, specificity, area under the receiver operating characteristic curve, and data from 2 × 2 tables. When a study reported several parameters from the same cohort, the results were treated as correlated. True-positive, false-negative, false-positive, and true-negative counts were reconstructed only when the published data yielded a unique integer solution. 2.4 Methodological quality and synthesis Risk of bias and applicability concerns were assessed using QUADAS-3 across the participants, index test, targetcondition determination, and analysis domains (University of Bristol, 2024). Judgments were based on the information reported in each study, and no overall numerical score was calculated. The assessment was performed by one reviewer and checked against the recorded rationales and extracted data. Studies were grouped according to the target condition, population, muscle examined, ultrasound parameter, and reference standard. Quantitative synthesis was considered only for clinically comparable groups with verifiable 2 × 2 tables. Under those conditions, sensitivity and specificity would be jointly estimated using a bivariate random-effects model or a hierarchical summary receiver operating characteristic model. When adequate comparability was not achieved, results were presented individually and discussed in a narrative synthesis. 2.5 Ethical considerations Because this review used only published data and information available in public registries, research ethics committee approval and participant consent were not required. 3. Results 3.1 Study selection The primary PubMed/MEDLINE search identified 1,401 records through September 8, 2026. After title and abstract screening, 124 records proceeded to full-text assessment. Supplementary searches in Europe PMC and Crossref added nine nonduplicate publications, and an updated search through September 17, 2026 identified seven additional publications, yielding 140 publications for assessment. Two study records without results were presented separately. 4 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 After the eligibility criteria were applied, 45 publications were included in the diagnostic accuracy synthesis, 77 were included in the secondary synthesis, and 13 were excluded. Five publications could not be obtained in full text and were not included in the analyses. Studies in which ultrasound itself formed part of the diagnostic definition were retained only in the secondary synthesis because of the risk of incorporation bias. Figure 1. Flow of publication identification, screening, and selection. Note: counts refer to publications. Records from the same cohort were linked during selection, and two registered studies without results were presented separately. Source: Research data, 2026. 3.2 Characteristics of the diagnostic accuracy studies The 45 publications included in the diagnostic accuracy synthesis were published between 2016 and 2026 and covered community-dwelling, geriatric, hospital, and chronic-disease populations. Because the independence of cohorts described in different publications could not always be confirmed, an aggregate participant total was not reported, thereby avoiding possible double counting. The main study characteristics are summarized in Table 1. Cross-sectional and prospective designs predominated. Populations were heterogeneous and included communitydwelling older adults, outpatients and inpatients, and groups with cancer, kidney disease, rheumatoid arthritis, Parkinson disease, transplantation, liver disease, and other chronic conditions. Given this spectrum heterogeneity, studies in younger or highly specific clinical populations were considered separately from the main geriatric population. Reference standards were based mainly on AWGS 2019, EWGSOP2, or variations of these consensus criteria, with muscle mass quantified using bioelectrical impedance analysis, DXA, or computed tomography. Operational definitions of the target condition differed and included confirmed sarcopenia, isolated low muscle mass, probable sarcopenia, and modified classifications. Consequently, findings carrying similar labels could not automatically be treated as equivalent. The rectus femoris was the most frequently examined muscle, either alone or together with the vastus intermedius. Other sites included the gastrocnemius, biceps brachii, brachioradialis, abdominal muscles, and multisite protocols. Index tests included muscle thickness, cross-sectional area, echo intensity, muscle architecture, shear-wave elastography, normalized indices, estimation equations, and artificial intelligence-assisted models. Cutoffs varied according to sex, muscle, position, normalization method, and clinical condition. 5 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Table 1. Characteristics of the 45 publications included in the diagnostic accuracy synthesis. Author/year Population Greece Patients referred to the sarcopenia outpatient clinic at Patras University 94 Hospital; 94 older adults (27 men and 67 women), mean age 75.6 years. Li et al., 2020 China A total of 179 adults aged >60 years from the health-management center of the First Affiliated 179 Hospital, Zhejiang University; 49 men and 130 women. Tada et al., 2021 Japan Eighty-four patients with rheumatoid arthritis (18 men 84 and 66 women). China/Japan Fifty-three patients aged ≥40 years with stable COPD from three centers in northern China; 23 healthy 53 controls were not included in the sarcopenia diagnostic accuracy analysis. AWGS 2019: low BIA muscle mass (<7.0 kg/m² in men; <5.7 kg/m² in women) Rectus femoris. plus low handgrip strength (<28/<18 kg) and/or five chair stands in ≥12 s. Mean shear-wave elastography value (kPa), thickness, and crosssectional area by B-mode ultrasound. Thailand A total of 857 communitydwelling adults aged ≥60 years from the Bangkok 857 Falls Study, Dusit, Bangkok; 269 men and 588 women. AWGS 2019: low ASM by BIA plus low handgrip strength and/or low physical Right rectus femoris. performance; severe sarcopenia required all three domains. B-mode thickness in the transverse plane with the participant supine. China Three Chinese cohorts of adults aged >60 years; cohorts 1–2 were used for model development and cohort 3 for external geographic/ethnic verification. AWGS 2019: low muscle For low SMI in model mass plus low handgrip development: 0.879 in men Four sites in proximal and Estimated SMI equation strength and/or low 4-m gait and 0.831 in women; the distal upper- and lower-limb based on four-site muscle 92.7% overall speed. Muscle mass was sarcopenia AUC in the segments. thickness, age, sex, and BMI. assessed using the InBody verification cohort was not 770 BIA device. reported. Barotsis et al., 2020 Deng et al., 2021 Sri-On et al., 2022 Tang et al., 2022 Fukuda et al., 2024 Japan n Consensus/reference Muscle Ultrasound parameter AUC Sensitivity standard EWGSOP2: low strength indicated probable sarcopenia; low muscle B-mode bilateral thickness in Geniohyoid, rectus femoris, quantity/quality confirmed transverse and longitudinal vastus intermedius, medial the diagnosis; low views; the geniohyoid 0.79 75.0% gastrocnemius, and other performance indicated severe measure was the besthead, neck, and limb sites. sarcopenia. Whole-body performing index. DXA was used to assess appendicular muscle mass. AWGS: low muscle mass plus low handgrip strength or 0.822 (95% CI 0.725–0.919) low gait speed (<0.8 m/s). Cross-sectional area, muscle for age + sex + CSA; 0.802 Cutoffs: SMI <7.0 kg/m² in thickness, and fat thickness; (0.688–0.916) for BMI + FT Dominant biceps brachii. NR men and <5.4 kg/m² in age + sex + CSA and BMI + + MT + CSA; 0.842 (0.752– women; handgrip strength FT + MT + CSA models. 0.933) in the updated <26/<18 kg. Muscle mass AWGS analysis. was assessed by DXA. Anterior-thigh muscle AWGS: low ASMI by BIA Anterior thigh: rectus 0.825 in men (95% CI thickness; fat thickness was plus low handgrip strength femoris plus vastus 0.620–1.000) and 0.745 in 52.6% overall assessed separately for and/or low gait speed. intermedius. women (0.573–0.916). obesity. Country 253 A total of 1,075 inpatients with cardiovascular disease; 1075 675 men and 400 women. de Luis Roman et al., 2024 Spain A total of 991 hospitalized patients at nutritional risk in the prospective Spanish 990 multicenter DRECO study; mean age 58.5 years. Zanotelli et al., 2024 Sixty cooperative older inpatients (30 women and 30 men); ten younger adults served only as ancillary 60 controls and were not included in the diagnostic accuracy analysis. Italy Earlier AWGS criteria: BIA SMI <7.0 kg/m² in men/<5.7 kg/m² in women AND Right anterior thigh at mid- B-mode anterior femoral handgrip strength <26/<18 thigh: rectus femoris plus muscle thickness in the kg OR gait speed ≤0.8 m/s. vastus intermedius. supine position. Muscle mass was assessed by multifrequency BIA (InBody S10). Reported algorithm: risk = SARC-F ≥4; probable sarcopenia = SARC-F ≥4 plus low handgrip strength; confirmed sarcopenia = probable sarcopenia plus BIA ASMM <7.0 kg/m² in men/<5.5 kg/m² in women; severe sarcopenia = confirmed sarcopenia plus TUG ≥20 s. Right rectus femoris. EWGSOP2 according to the authors: low strength plus low muscle mass; ASMI by Rectus femoris. BIA <7.0 kg/m² in men/<5.5 kg/m² in women. 6 Specificity Quantitative inclusion 66.7% Yes—candidate NR No—narrative synthesis 95.4% overall Yes—candidate SWEmean 0.863; thickness NR 0.802; CSA 0.816. NR No—narrative synthesis 0.92 (95% CI 0.89–0.94) for sarcopenia; 0.95 (0.92–0.98) 90.9% for severe sarcopenia. 92.2% Yes—candidate 91.0% overall Yes—candidate 77.6% in men; 66.0% in women No—narrative synthesis 0.796 in men; 0.746 in women. 68.5% in men; 70.5% in women Cross-sectional area, X and Confirmed-sarcopenia CSA: Confirmed-sarcopenia CSA: Confirmed-sarcopenia CSA: Y axes, and X/Y ratio in the 0.680 overall, 0.777 in men, 81.0% overall; 81.4% in 49.5% overall; 66.4% in No—narrative synthesis supine position; CSA was the and 0.483 in women. men; 89.1% in women men; 16.3% in women primary candidate. Cross-sectional area, thickness, echogenicity, and CSA 0.852 in women/0.867 100% in both sexes, based compressibility; muscle in men; MQI 0.900 in on the reported counts quality index = CSA × BIA women/0.969 in men. phase angle. 78.9% in women and 80.0% in men, based on the Yes—candidate reported counts Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Author/year Country Population Yik et al., 2024 NR Thirty-six adults from a preoperative outpatient clinic; median age 69.5 36 years, with an inconsistently reported range of 26–81/87 years; 17 men. Fernández-Jiménez et al., 2024 Spain Outpatients with idiopathic pulmonary fibrosis in a prospective two-center 84 study; mean age 71.0 years; 83.5% men. Han et al., 2025 China Patients with essential hypertension in a crosssectional study in China. n 134 Consensus/reference Muscle standard AWGS 2019: low ASM by BIA (<7.0 kg/m² in men/<5.7 kg/m² in women) plus low handgrip strength (<28/<18 Bilateral rectus femoris. kg) OR low performance (6m gait speed <1.0 m/s; the table also reports chair stand/SPPB). EWGSOP2: probable sarcopenia by handgrip strength <27 kg in men/<16 kg in women; confirmed sarcopenia combined low strength with ASMM <20 kg Right rectus femoris. in men/<15 kg in women or ASMI <7.0/<5.5 kg/m². Muscle mass was assessed by BIVA (AKERN V101), termed BIVA-sarcopenia. AWGS 2019: low muscle mass plus low handgrip strength and/or low physical Rectus femoris and medial performance. ASMI was gastrocnemius. used to define low muscle mass; the body-composition method was not reported. Wei et al., 2025 China Hospitalized geriatric patients aged ≥60 years in China; retrospective controlled study. Zehnder et al., 2025 NR Older inpatients from a consecutive acute-geriatric cohort. Chen et al., 2025 China Adults prospectively assessed at multiple centers; 584 development and externalvalidation cohorts. Spain Seventy-four clinically stable adults receiving 74 maintenance hemodialysis in Spain. De La Flor et al., 2025 167 161 AWGS 2019: ASM/height² ≤7.0 kg/m² in men or ≤5.7 kg/m² in women, plus Bilateral brachioradialis, handgrip strength <28/<18 vastus medialis, and kg and/or 6-m gait speed medial/lateral <1.0 m/s. Muscle mass was gastrocnemius. assessed by BIA using a Jevon IO1 analyzer. EWGSOP2: low strength plus low muscle quantity for confirmed sarcopenia; Rectus femoris. muscle mass was assessed by BIA. AWGS 2019 in the training and external-validation cohorts; the proof-of-concept cohort used low CT L3-SMI. Rectus femoris. BIA/ASMI was used in the AWGS cohorts and CT L3SMI in the proof-of-concept cohort. EWGSOP2, fully operationalized as described Rectus femoris. in the article; muscle mass was assessed by BIA. Ultrasound parameter AUC Sensitivity Specificity Quantitative inclusion AI-assisted MuscleSound measures: IMAT percentage, IMAT index 0.727 (95% CI muscle area, and IMAT 0.551–0.904); IMAT 81.8% index (IMAT percentage 0.553. percentage/muscle area). 68.0% Yes—candidate Cross-sectional area and Y0.833 for RF-CSA; 0.730 for 75.76% for RF-CSA; axis at rest; mean of three the Y-axis. 60.61% for the Y-axis measurements; Mindray Z60. 88.24% for RF-CSA; 82.35% for the Y-axis No—narrative synthesis Rectus femoris thickness, CSA, and SWE at rest and during contraction; medial gastrocnemius fascicle length, pennation angle, thickness, and SWE; combined 2D ultrasound + SWE model. Parameters/models ranged from 0.806 to 0.987; the exact AUC for each index requires the original table. 90.8% for the combined model No—narrative synthesis Muscle thickness; ultrasound-traced maximum calf muscle circumference; model including age, albumin, BR-MT, Glh-MT, and calf circumference. 0.927 for the simplified model; 0.925 for the original 95.9% for calf model; individual AUC circumference; 88.4% for values were reported in the model Table 4. 84.5% for the combined model Point-of-care ultrasound 0.64 for thickness; 0.61 for thickness and cross-sectional NR CSA. area. CNN-processed images; unimodal ultrasound and multimodal/combined models. Not reported in the main text for calf circumference; No—narrative synthesis 83.7% for the model NR No—narrative synthesis 0.827 in training; 0.851 in 73.3% in training; 70.5% in 78.2% in training; 79.4% in complete-case analysis; external validation; 78.9% external validation; 82.5% 0.801 in external validation; Yes—candidate in the proof-of-concept in the proof-of-concept 0.757 in the proof-ofcohort cohort concept cohort. Y-axis, Y-axis/height, crosssectional muscle area of the 0.67 for the Y-axis; 0.67 for rectus femoris (CS-MARF), Y-axis/height; 0.65 for CS- Not reported CS-MARF/height² MARF; 0.63 for MARFIh. (MARFIh), and Not reported No—narrative synthesis Muscle thickness, crosssectional area, and subcutaneous-fat thickness; 0.87 for rectus femoris CSA. 86% rectus femoris CSA was the best-performing marker. 83% No—narrative synthesis Muscle thickness. Not reported Not reported Not reported No—narrative synthesis Point-of-care ultrasound muscle thickness. 0.652 in women and 0.905 in men. NR NR No—narrative synthesis supramuscular fat. China A prospective Chinese cohort of 167 patients with diffuse large B-cell lymphoma. Aghi et al., 2025 NR Forty-one liver-transplant recipients or candidates and 41 healthy donors; ROC 82 analysis was restricted to 38 male recipients. Mondo et al., 2025 NR Prospective cohort of 126 geriatric patients with hip fracture; only 52 had paired 52 DXA and point-of-care ultrasound measurements. Liu et al., 2025 167 Consensus-defined sarcopenia as described in the source publication; the Biceps brachii, vastus exact consensus version, intermedius, and rectus cutoffs, and conventional femoris. muscle-mass method were not reported. Low CT-derived L3 skeletal muscle index plus handgrip External oblique, internal strength; the definition was oblique, and transversus not clearly equivalent to a abdominis. complete EWGSOP or AWGS reference standard. EWGSOP2; muscle mass was assessed by DXA. Rectus femoris. 7 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Author/year Lim et al., 2025 Qin et al., 2025 López-Gómez et al., 2025 Wang et al., 2025 Country Population Taiwan Eighty-five consecutive patients with idiopathic Parkinson disease in Taiwan; median age 73.0 85 years among cases and 66.5 years among noncases; 41 men and 44 women. China Spain China n Retrospective case-control study in China including 101 endocrinology patients 202 with sarcopenia and 101 healthy controls, aged 55–85 years. A total of 337 oncology patients receiving curative treatment or undergoing pretreatment assessment in a high-risk nutritional clinic in Spain; 58.8% were men and mean age was 69.7 years. 300 Complete data were available for 300 participants (26 cases and 274 noncases), although the flow diagram reported 27 cases among 337 participants. A total of 178 patients receiving peritoneal dialysis for ≥3 months in China; 60 178 had sarcopenia. The report listed 118 noncases in a table and 117 in the text. Brockhattingen et al., 2025 Denmark Twenty-four older adults attending a falls clinic in Denmark; 15 were women 24 and mean age was 81 years. Eight participants declined DXA. Shou et al., 2025 China A total of 114 clinically stable patients with cardiovascular disease in China; mean age 65.16 years; 45 men and 69 women. Pus et al., 2026 Italy/Slovenia A total of 139 adults aged ≥65 years from Italy and Slovenia (51 in Slovenia and 139 88 in Italy); 54% were women and mean age was 78.23 years. Lee et al., 2026 South Korea A total of 145 communitydwelling South Korean women aged 65–80 years; mean age 72.3 years. de la Torre et al., 2026 Spain/Portugal Wang et al., 2026 China 114 145 A single-center cohort of 115 adults receiving hemodialysis in Portugal; 115 median age 73 years; 67% were men and 93.5% were White. A total of 158 patients with primary breast cancer 158 assessed before neoadjuvant chemotherapy. Consensus/reference standard Muscle AWGS 2019; muscle mass was assessed by DXA. Muscle thickness, crosssectional area, and shearwave elastography; biceps Nondominant biceps 0.732 for MTBB; 0.857 for brachii thickness (MTBB) 71.0% for MTBB; 80.6% brachii, rectus femoris, and the age + BMI + MTBB was the best individual for the model tibialis anterior. model. marker, and an age + BMI + MTBB model was also evaluated. Reported as AWGS 2019, but with modified DXA thresholds; applicability of the reference standard was therefore problematic. Medial gastrocnemius. Ultrasound parameter EWGSOP2: low handgrip strength plus low CT-derived L3 skeletal muscle index Rectus femoris. using Martin cutoffs; physical performance was not assessed. AUC Longitudinal-region histogram features; the 75th 0.988. percentile was the bestperforming feature. Sensitivity 96% Dominant rectus femoris. Low handgrip strength plus low CT-derived T12 skeletal Gastrocnemius. muscle index. 8 Quantitative inclusion 70.4% for MTBB; 79.6% for the model Yes—candidate 95% No—narrative synthesis AI-assisted transverse rectus Rectus femoris area: 0.628 femoris area normalized to overall; rectus femoris 55.25% for area; 54.9% for 66.67% for area; 74.1% for height, thickness, pennation thickness: 0.636 overall; No—narrative synthesis thickness thickness angle, and tissue-percentage sex-specific estimates were measures. also reported. Restrictive AWGS 2019 Muscle thickness, pennation definition: low BIA-derived angle, fascicle length, ASMI AND low handgrip attenuation-derived radiomic Right medial gastrocnemius. 0.902 for the nomogram. 77.3% strength; gait speed was features, and echo intensity; measured but was not a five-parameter nomogram included in the classifier. was developed. The SARCHO protocol replaced DXA with EWGSOP2 using handgrip ultrasound-predicted strength, absolute appendicular skeletal muscle appendicular skeletal muscle mass derived from arm and Composite diagnostic Upper arm and thigh sites. 77.8% (95% CI 55.4–88.7) mass, and physical thigh thickness plus age, sex, accuracy; AUC not reported. performance; muscle mass weight, and height; was assessed by DXA. additional ultrasound measures were also collected. Resting and passive-stretch thickness, CSA, muscle and Individual components: fat measurements, focal AWGS 2019; muscle mass Rectus femoris and vastus 0.710, 0.764, 0.778, and 83.3% for the combined myosteatosis, and was assessed by DXA. intermedius. 0.870; combined model: model SWE/shear-wave velocity; a 0.921. combined model was evaluated. EWGSOP2 and a modified Sarcopenia Definitions and Fascicle length, muscle USI: 0.673 against Outcomes Consortium thickness, pennation angle, EWGSOP2 and 0.566 Right distal vastus lateralis. NR definition based on Westbury and an ultrasound sarcopenia against the modified SDOC criteria; muscle mass was index (USI). definition. assessed by DXA. AWGS 2025 for women: Quadriceps thickness (QFT), QFT 0.866; VLT 0.817; BIA-derived SMI <5.4 kg/m² Right thigh: quadriceps, vastus lateralis thickness RFCSA 0.838; score 0.914; QFT 100%; VLT 87.5%; AND handgrip strength <18 vastus lateralis, and rectus (VLT), rectus femoris CSA apparent logistic model RFCSA 62.5%; score kg; physical performance femoris. (RFCSA), and a LASSO0.871; bootstrap-corrected 87.5% was not included. derived score. model 0.846. EWGSOP2: low handgrip strength plus low BISderived ASMI; physical performance determined severity. Specificity 56.7% No—narrative synthesis 100% (95% CI 100–100) No—narrative synthesis 89.7% for the combined model No—narrative synthesis NR No—narrative synthesis QFT 64.2%; VLT 73.0%; RFCSA 92.0%; score 86.1% Yes—candidate Rectus femoris thickness and 0.73 for thickness and 0.72 cross-sectional area. for CSA. 74% for thickness; 84% for 66.2% for thickness; 53.9% Yes—candidate CSA for CSA Muscle thickness, pennation angle, resting Young 0.911 (95% CI 0.868– modulus, and age in a 0.954). multivariable nomogram. 86.1% 72.6% No—secondary narrative synthesis Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Author/year Guo et al., 2023 Zhao et al., 2026 Country China China Kılıç et al., 2026 Türkiye Kuyumcu et al., 2016 Türkiye Rustani et al., 2019 Italy Population n A total of 169 adults aged 52–81 years with end-stage kidney disease receiving 169 hemodialysis; 63 had sarcopenia and 106 did not. A total of 102 patients with Hoehn–Yahr stage I–II Parkinson disease and 38 102 healthy controls; counts by sarcopenia stage were not reported. Fifty-one patients with rheumatoid arthritis (19 with and 32 without sarcopenia) and 51 controls. Diagnostic accuracy analysis was 51 restricted to the rheumatoidarthritis group; the stated age range was 18–65 years, although the table included ages up to 77 years. One hundred older adults in Türkiye; mean age 73.08 100 years. A total of 119 internalmedicine inpatients in Italy; 119 mean age 82 years; 50.4% Consensus/reference standard Muscle Ultrasound parameter Sensitivity Specificity Quantitative inclusion AWGS 2019 using BIAderived muscle mass and handgrip strength. Gastrocnemius. Thickness, pennation angle, fascicle length, Young modulus, and shear-wave velocity at rest and during stretch; nomogram including age, BMI, and hs-CRP. 0.852 for the nomogram; CNot reported Component cutoffs included index 0.845. thickness ≤12.36 mm, stretched Young modulus ≤25.32 kPa, and stretched shear-wave velocity ≤4.55 m/s. Not reported No—secondary narrative synthesis The diagnostic criteria and thresholds used for the sarcopenia stages were not reported. Bilateral brachioradialis, biceps brachii, and medial gastrocnemius. Shear-wave velocity at rest and during functional maneuvers. Not reported Not reported Not reported No—secondary narrative synthesis Low handgrip strength plus low DXA-derived skeletal muscle mass index. The Rectus femoris, vastus Bilateral rectus femoris and authors cited EWGSOP, but intermedius, and total vastus intermedius. reported handgrip thresholds quadriceps thickness. of 32/22 kg and SMMI thresholds of 9.2/7.4 kg/m². Not reported Not reported Not reported No—secondary narrative synthesis BIA-derived fat-free mass Bilateral medial index plus handgrip strength, gastrocnemius. compatible with EWGSOP1. Muscle thickness and fascicle length. Thickness: 0.78 and 0.83; fascicle length: 0.80 and 0.78 for the two sides. >76.92% across the four measures; measure-specific Not reported values not reported No—narrative synthesis EWGSOP1. B-mode muscle thickness; 0.90 overall; 0.94 in men; cutoffs of 0.9 cm in men and 0.92 in women. 0.7 cm in women. 100% 64% No—narrative synthesis Muscle diameter using a 15Not reported mm cutoff. 76.7% 80.8% No—narrative synthesis Rectus femoris. were women. Sato et al., 2020 Japan A total of 185 consecutive patients with heart failure in 185 Japan. Ozturk et al., 2022 Türkiye A total of 313 geriatric outpatients aged ≥65 years in Türkiye; 42 had confirmed sarcopenia. 313 Chen et al., 2023 China Eighty-four older adults with type 2 diabetes in China; 30 had sarcopenia and 54 did not. 84 Wang et al., 2023 China Güner et al., 2024 Türkiye Yoshida et al., 2024 Japan Zhang et al., 2024 Chen et al., 2025 A total of 130 hospitalized Chinese adults classified as 130 healthy or as having sarcopenia. Forty-five patients receiving maintenance hemodialysis for >6 months, three 45 sessions per week, in Türkiye. A total of 1,229 independent community-dwelling 1229 Japanese adults aged 65–91 years. AUC The operational definition was not detailed; a related Rectus femoris. review classified the criterion as AWGS 2014. Handgrip strength plus BIAMedial gastrocnemius, derived muscle mass; the rectus femoris, and rectus named consensus was not abdominis. reported in the abstract. Medial gastrocnemius: 0.817 Muscle thickness and sexin women and 0.707 in men; specific rectus femoris CSA Not reported Not reported additional muscle-specific cutoffs. AUCs were reported. Thickness, CSA, shear-wave Low ASMI plus low strength elastography in extended and and/or physical performance; 0.883 for the combined Rectus femoris. flexed positions, positional 83.3% 83.3% the named consensus was not model. differences, and a combined reported. model. >0.80 for the tibialis anterior Shear-wave elastography; Tibialis anterior, medial and medial gastrocnemius; 84.62% associated with the AWGS 2019. reported cutoffs included 81.54% gastrocnemius, and soleus. muscle-specific values were 3.02 cutoff 3.02 and 2.26. not reported. Rectus femoris, medial Muscle thickness and CSA; EWGSOP2; the full gastrocnemius, rectus the best-performing measure operational definition was abdominis, external and Not reported Not reported Not reported was rectus femoris CSA, not reported. internal obliques, and with a cutoff of 4.61. transversus abdominis. B-mode muscle thickness; 0.901 in men and 0.923 in cutoffs of 4.0 cm in men and women. 3.1 cm in women. AWGS 2019. Right mid-anterior thigh. China Patients receiving maintenance hemodialysis and healthy controls in NR China; sample size was not reported. AWGS 2019. Muscle thickness, pennation angle, fascicle length, CSA, echo intensity, elastic Left medial gastrocnemius properties, shear-wave Not reported head. velocity, microvascular measures, and a combined equation using a 0.69 cutoff. China A total of 145 postmenopausal women with osteopenia or osteoporosis; 115 did not and 30 did have osteosarcopenia. Osteosarcopenia was defined by coexisting low bone mineral density and sarcopenia based on ASMI, Rectus femoris. handgrip strength, and the 6m chair-stand test; exact cutoffs were not reported. 145 9 No—narrative synthesis No—narrative synthesis No—narrative synthesis No—narrative synthesis 84.2% in men; 80.0% in women 80.2% in men; 92.1% in women Yes—verifiable 2 × 2 table Not reported Not reported No—narrative synthesis 93% No—narrative synthesis Thickness, CSA, shear-wave 0.917 for the combined velocity, and a combined model; component estimates 70% model. were also reported. Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Author/year Chiu et al., 2025 Dong et al., 2025 Fu et al., 2025 Country Taiwan China China Population n One hundred adults aged 20–70 years with end-stage kidney disease in Taiwan; 100 48 had and 52 did not have sarcopenia. Seventy-six Chinese patients with COPD (46 with and 30 without sarcopenia); the shear-wave elastography 76 subset included 42 patients, and 30 healthy controls were included for reliability analyses. A total of 628 older residents from 15 long-termcare facilities in China; sarcopenia prevalence was 628 61.9%; 70% were assigned to training and 30% to validation. Consensus/reference Muscle standard EWGSOP2: low handgrip strength plus low DXAderived ASM/height²; gait Quadriceps. speed was used to determine severity. Ultrasound parameter Sensitivity Specificity Quantitative inclusion 82.4% 66.7% No—narrative synthesis Thickness, rectus femoris CSA, biceps brachii CSA, diaphragm thickening 0.916 and 0.961 for SWEfraction and excursion, 90.5% for both subset based models; 0.956 for the intercostal muscle thickening models full morphologic model. fraction, shear-wave velocity, and combined models. 81.0% and 100% in the subset Yes—2 × 2 table in the subset Validation AUCs for Thickness, echo intensity, conventional models were radiomics, and integrated approximately 0.70, 0.73, age-, sex-, and BMI-adjusted and 0.75; additional models. radiomic and integrated estimates were reported. Not reported No—narrative synthesis Strain elastography elasticity ratio/muscle stiffness; cutoff Not reported 0.885. AWGS 2019/EWGSOP2 Diaphragm, intercostal using BIA-derived ASMI muscles, rectus abdominis, plus strength and/or physical rectus femoris, and biceps performance. brachii. AWGS 2019. AUC Rectus femoris, vastus intermedius, and quadriceps. Not reported Note: NR = not reported; US = ultrasonography; AUC = area under the receiver operating characteristic curve. Publication-to-cohort correspondence was verified using the available data. 10 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 3.3 Diagnostic performance and feasibility of quantitative synthesis Twelve studies provided 2 × 2 tables that had been previously verified or could be reconstructed from exact denominators and counts. Results based solely on rounded percentages were not converted into approximate counts. The remaining diagnostic accuracy studies mainly reported AUC, sensitivity, or specificity without adequate denominators; multivariable models; incomplete stratified results; or internally derived thresholds. When a study reported more than one model or parameter, the findings were treated as correlated rather than as independent samples. The updated search added two studies to the diagnostic accuracy synthesis and four to the secondary synthesis. One record was not included because the target condition could not be confirmed from the available information. No sufficiently homogeneous group was identified for meta-analysis. Three independent studies evaluated rectus femoris cross-sectional area using complete consensus criteria; sensitivity ranged from 62.5% to 100.0%, and specificity ranged from 53.8% to 92.0%. Differences in populations, diagnostic criteria, and cutoffs, together with the small number of cases in one study, precluded a reliable pooled estimate. The findings were therefore presented individually in Figure 2. Figure 2. Sensitivity and specificity of rectus femoris cross-sectional area in the three studies with verifiable 2 × 2 tables. Note: estimates are shown individually because of clinical and methodological heterogeneity among the studies. Source: Research data (2026). 3.4 Clinical role of ultrasound Most studies evaluated ultrasound as a potential replacement or screening tool when DXA, computed tomography, or other methods were unavailable. A smaller proportion incorporated ultrasound parameters into clinical, laboratory, or artificial intelligence models. Most of these models, however, were developed and evaluated in the same sample. Evidence of incremental value in the strict sense—a paired comparison of the conventional method alone with the same method plus ultrasound—was insufficient. Improvements in AUC within composite models were therefore interpreted as exploratory evidence of complementary potential rather than proof of additional clinical benefit. 3.5 Risk of bias and applicability QUADAS-3 assessment was completed for 41 of the 45 publications in the diagnostic accuracy synthesis. Thirty-eight studies had an overall high risk of bias and three had an overall unclear risk; none was classified as having a low overall risk. By domain, risk was high in 12 studies for participant selection, 36 for the index test, 4 for target-condition determination, and 32 for analysis. The most frequent limitations were convenience or case-control sampling, incomplete descriptions of recruitment, cutoffs derived and tested in the same sample, selection among multiple parameters, lack of external validation, poorly described blinding, inconsistent denominators, and incomplete reporting of analyses. Thirty-one of the 41 assessed studies raised high overall applicability concerns, whereas ten raised low concerns. The main reasons were the inclusion of disease-specific populations, anatomical and technical variability in the index test, and the use of target conditions other than confirmed sarcopenia. Four publications in the diagnostic accuracy synthesis were not assessed with QUADAS-3. The domain-level judgments are summarized in Table 2. 11 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Table 2. Summary of risk of bias using QUADAS-3 in 41 studies. Order PMID Overall risk Applicability High-risk domains Unclear domains 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 32293812 33173415 34278004 35069243 36003922 36580560 38269334 38892486 39125310 39203903 39698245 39839028 39910436 40095583 40327860 40572732 40626603 40687188 40807045 40829775 40893571 41080186 41225978 41341113 41459406 41887544 41974856 42650893 27107379 31029040 31701229 35660496 36000347 36648552 37888199 38128851 38849074 39854271 40882952 41425629 41458303 High High High Unclear High Unclear High High High High High High High High High High High High High High High High High High High High High High High High High High High High High High High High Unclear High High Low High High High Low Low High High Low High High High High Low High High High High High High High High High High High High High High Low High High Low Low High Low High High High Low High High Index test Index test; Analysis Index test NR Index test; Analysis NR Index test Index test Index test; Analysis Index test; Analysis Index test; Analysis Index test; Analysis Participants; Index test; Analysis Index test Index test; Analysis Index test; Analysis Index test; Analysis Participants; Index test; Target condition; Analysis Participants; Index test; Analysis Index test; Analysis Participants; Index test; Target condition; Analysis Participants; Index test; Analysis Index test; Target condition; Analysis Participants; Target condition; Analysis Index test; Analysis Analysis Index test; Analysis Index test Index test, Analysis Participants, Index test, Analysis Participants, Index test, Analysis Index test, Analysis Index test, Analysis Participants, Index test, Analysis Index test, Analysis Index test, Analysis Participants, Index test, Analysis Participants, Index test, Analysis None Index test, Analysis Participants, Index test, Analysis Participants; Target condition; Analysis Participants Analysis Participants; Index test; Analysis NR Participants Participants; Analysis Analysis Participants Participants Participants Participants NR Analysis Participants Participants; Target condition Participants; Target condition NR NR NR NR Target condition Participants Index test Participants Participants; Index test; Target condition Participants Participants Participants None Target condition Participants Participants None Participants Participants None None Analysis Participants None Note: assessments were performed by one reviewer and were based on the information reported in each study. Four publications in the diagnostic accuracy synthesis were not assessed with QUADAS-3. 12 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 4. Discussion The findings of this review indicate that muscle ultrasound may assist in identifying sarcopenia, but it should not yet be regarded as a stand-alone diagnostic test. Studies of community-dwelling older adults, hospitalized patients, and diverse clinical populations have demonstrated discriminatory ability for muscle thickness, cross-sectional area, and mechanical properties. The wide range of findings, however, shows that performance depends on the muscle examined, the protocol used, and the criterion adopted to define sarcopenia (Barotsis et al., 2020; Sri-On et al., 2022; Zanotelli et al., 2024; Yoshida et al., 2024). The rectus femoris was the most extensively investigated site. Its superficial position facilitates examination and favors bedside use, which explains its inclusion in geriatric, cardiovascular, pulmonary, kidney, and oncology studies. Despite this practical advantage, muscle thickness and cross-sectional area did not perform consistently. Rustani et al. (2019) found good screening ability for muscle thickness, whereas Sri-On et al. (2022) and Yoshida et al. (2024) reported favorable findings in older adults. More modest values were observed in hospitalized patients and some clinical populations (Zehnder et al., 2025; Mondo et al., 2025). Technical diversity also precludes treating “muscle ultrasound” as a single test. Thickness and area primarily reflect muscle quantity, whereas echogenicity, elastography, and architectural measures are intended to represent composition and mechanical properties. Studies of the biceps brachii, gastrocnemius, and quadriceps showed that several parameters may discriminate sarcopenia, but their cutoffs were obtained in specific populations and were generally derived in the same sample in which performance was evaluated (Li et al., 2020; Kuyumcu et al., 2016; Deng et al., 2021; Chen et al., 2023; Wang et al., 2023; Shou et al., 2025). The population examined was an important source of variation. In kidney disease, changes in fluid status may affect both the bioelectrical impedance analysis used in the reference standard and muscle thickness or elasticity. Studies in hemodialysis and peritoneal dialysis populations reported promising findings but evaluated different muscles, criteria, and models (Güner et al., 2024; De La Flor et al., 2025; Wang et al., 2025; Chiu et al., 2025; de la Torre et al., 2026). A similar issue arose in pulmonary disease, cancer, and Parkinson disease, where inflammation, treatment, activity level, and disease severity may alter the relationship between ultrasound measurements and sarcopenia (Deng et al., 2021; Fernández-Jiménez et al., 2024; Lim et al., 2025; Liu et al., 2025; Dong et al., 2025; Zhao et al., 2026). Rectus femoris cross-sectional area was the only parameter supported by three independent studies with verifiable 2 × 2 tables. Zanotelli et al. (2024), Lee et al. (2026), and de la Torre et al. (2026) reported sensitivities ranging from 62.5% to 100% and specificities ranging from 53.8% to 92.0%. This spread cannot be attributed to chance alone: the studies involved hospitalized older adults, community-dwelling women, and people receiving hemodialysis and used different diagnostic criteria and thresholds. Under these circumstances, a pooled estimate would create an appearance of precision without representing a clinically uniform protocol. This interpretation is more conservative than those of earlier meta-analyses but does not contradict the potential they identified. Fu et al. (2023) found low-to-moderate performance, with pooled sensitivity and specificity of 0.72 for rectus femoris thickness. Yang et al. (2025) estimated a sensitivity of 0.85 and specificity of 0.74 for muscle-thickness measurements in older adults. Both reviews, however, acknowledged heterogeneity in muscles, cutoffs, and reference standards. By requiring simultaneous comparability in population, test, target condition, and clinical role, the present review found an insufficient basis for a single summary estimate. In chronic kidney disease, the review by Yang et al. (2024) reported a sensitivity of 0.95 and specificity of 0.73 across studies of cross-sectional area and elastography. More recent studies reinforce the feasibility of bedside assessment but also show that morphological and mechanical parameters should not be combined as though they measured the same property. Moreover, 13 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 the influence of hydration requires protocols that specify the timing of examination relative to dialysis and the patient’s clinical condition (Güner et al., 2024; Zhang & Yang, 2024; Chiu et al., 2025; de la Torre et al., 2026). Composite models, radiomics, and artificial intelligence have expanded the range of analytical approaches. Favorable findings have been reported for rectus femoris image-based models, combinations of clinical and ultrasound parameters, and machine-learning systems (Yik et al., 2024; Chen et al., 2025; Fu et al., 2025; López-Gómez et al., 2025; Wei et al., 2025). Most of these models, however, were developed and tested in the same population. Without external validation, the apparent gain in performance may reflect overfitting or the contribution of variables such as age, sex, and body mass index rather than the specific value of ultrasound. The QUADAS-3 assessment reinforces this concern. Thirty-eight of the 41 studies had a high overall risk of bias, mainly because cutoffs were derived and evaluated in the same sample, multiple parameters were tested before the best-performing result was selected, and external validation was uncommon. High areas under the curve should therefore be interpreted as initial performance under study-specific conditions rather than confirmation that the same cutoff will perform similarly in another population. The studies by Rustani et al. (2019), Brockhattingen et al. (2025), Mondo et al. (2025), and Zehnder et al. (2025) help clarify the most plausible clinical role of the method. Its speed, portability, and ability to assess patients with limited mobility favor its use for screening or as an adjunct to conventional assessment. This role is particularly relevant where DXA or computed tomography is not readily available. Even so, positive ultrasound findings should be interpreted alongside muscle strength, physical performance, and clinical assessment, as recommended by sarcopenia consensus statements (Cruz-Jentoft et al., 2019; Chen et al., 2020). Replacement of conventional methods would require between-operator reproducibility, prespecified cutoffs, and consistent performance across centers. These conditions have not yet been demonstrated. Even studies reporting favorable results used specific protocols for participant position, measurement site, and normalization, which limits the direct application of their thresholds in other services (Barotsis et al., 2020; Tang et al., 2022; Sri-On et al., 2022; Yoshida et al., 2024). Incremental value in the strict sense has likewise not been established. Some models achieved higher AUCs when ultrasound parameters were combined with age, body mass index, albumin, or other variables, but few made a paired comparison between a prespecified conventional model and the same model with ultrasound added. These findings therefore suggest complementary potential but do not demonstrate improved clinical decision-making (Tang et al., 2022; Wei et al., 2025; Wang et al., 2025; Chen et al., 2025). The choice of cutoff should reflect the intended purpose of the examination. Greater sensitivity may be desirable in screening to reduce false-negative results, whereas a replacement test would require simultaneously high sensitivity, specificity, and reproducibility. Many studies used the Youden index in the development sample. Although this provides a statistical balance, it does not account for prevalence, costs, or the clinical consequences of misclassification (Rustani et al., 2019; Sri-On et al., 2022; Lim et al., 2025; Lee et al., 2026). Standardization remains essential. Participant position, anatomical landmark, transducer orientation and pressure, contraction state, equipment settings, and image processing should be described in a reproducible manner. The SARCUS recommendations provide an important foundation, but their application across studies remains inconsistent (Nijholt et al., 2017; Perkisas et al., 2021). Simpler protocols may have greater clinical utility, provided that they retain adequate reliability and are validated in different populations. This review has limitations. The search focused on PubMed/MEDLINE and supplementary open sources, which may have missed studies indexed exclusively in other databases. Study selection and methodological assessment were conducted 14 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 without independent review by a second reviewer. Publications also differed substantially in their descriptions of participants, thresholds, and contingency tables. These limitations, together with the small number of genuinely comparable studies, should be considered when interpreting the findings. Future studies should recruit consecutive, representative samples, prespecify the clinical role of the test, and apply consensus diagnostic criteria. Cutoffs should be defined before analysis or validated in independent cohorts. Complete 2 × 2 tables should be reported, interobserver agreement should be assessed, and the conventional approach should be directly compared with the same approach supplemented by ultrasound. Taken together, the evidence provides a favorable but cautious answer to the question addressed in this review. Muscle ultrasound may complement sarcopenia assessment and offers clear practical advantages, particularly for screening and bedside care. Its use alone as a replacement for DXA, BIA, computed tomography, or tests of strength and physical performance remains insufficiently supported because no muscle, parameter, or cutoff has been consistently validated across populations. 5. Conclusion Muscle ultrasound may complement conventional sarcopenia assessment, particularly as a portable screening and bedside morphological assessment tool. The available evidence, however, does not yet support replacing established methods, defining a universal parameter or muscle, adopting generalizable cutoffs, or claiming proven incremental clinical value. Observed performance depends on the muscle, ultrasound parameter, technical protocol, population, and definition of the target condition. Between-study heterogeneity, predominantly high risk of bias, and limited external validation precluded a clinically defensible primary meta-analysis. The findings should therefore be interpreted as evidence of diagnostic potential rather than definitive validation for stand-alone use. Prospective multicenter studies using standardized protocols, prespecified thresholds, complete reporting of diagnostic accuracy, and external validation are needed to determine the settings in which ultrasound offers additional benefit and how it should be integrated with measures of strength, physical performance, and body composition. References Aghi, S., Dhingra, U., Sindwani, G., Yadav, A., Benjamin, J., Bansal, K., Pamecha, V., & Tempe, D. K. (2025). Ultrasound assessment of abdominal wall muscle thickness in liver transplant recipients and healthy donors: a comparative study for the assessment of sarcopenia. Journal of ultrasonography, 25(101), 20250020. https://doi.org/10.15557/jou.2025.0020 Barotsis, N., Galata, A., Hadjiconstanti, A., & Panayiotakis, G. (2020). The ultrasonographic measurement of muscle thickness in sarcopenia. A prediction study. European journal of physical and rehabilitation medicine, 56(4), 427-437. https://doi.org/10.23736/S1973-9087.20.06222-X Brockhattingen, K. K., Perkisas, S., Jepsen, D. B., Gram, F., Ryg, J., & Andersen-Ranberg, K. (2025). Assessing SARCopenia with ecHOgraphy in CommunityDwelling Older Adults: A Validation Study (SARCHO). Journal of frailty, sarcopenia and falls, 10(4), 206-217. https://doi.org/10.22540/JFSF-10-206 Chen, L. K., Hsiao, F. Y., Akishita, M., Assantachai, P., Lee, W. J., Lim, W. S., Muangpaisan, W., Kim, M., Merchant, R. A., Peng, L. N., Tan, M. P., Won, C. W., Yamada, M., Woo, J., & Arai, H. (2025). A focus shift from sarcopenia to muscle health in the Asian Working Group for Sarcopenia 2025 Consensus Update. Nature Aging, 5(11), 2164-2175. https://doi.org/10.1038/s43587-025-01004-y Chen, L. K., Woo, J., Assantachai, P., Auyeung, T. W., Chou, M. Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., Kojima, T., Kuzuya, M., Lee, J. S. W., Lee, S. Y., Lee, W. J., Lee, Y., Liang, C. K., Lim, J. Y., Lim, W. S., … Arai, H. (2020). Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Directors Association, 21(3), 300-307.e2. https://doi.org/10.1016/j.jamda.2019.12.012 Chen, Z. T., Ge, J. Y., Jin, F. S., Guo, L. H., Wang, Q., Zhao, H., Sun, L. P., Xu, H. X., Sheng, H., Li, X. L., China Alliance of Multi-Center Clinical Study for Ultrasound (Ultra-Chance) (2025). The value of ultrasound-measured rectus femoris thickness, cross-sectional area, and shear wave velocity in assessment of muscle in postmenopausal women with osteosarcopenia. The British journal of radiology, 98(1173), 1456-1462. https://doi.org/10.1093/bjr/tqaf012 Chen, Z. T., Jin, F. S., Guo, L. H., Li, X. L., Wang, Q., Zhao, H., Sun, L. P., Xu, H. X. (2023). Value of conventional ultrasound and shear wave elastography in the assessment of muscle mass and function in elderly people with type 2 diabetes. European radiology, 33(6), 4007-4015. https://doi.org/10.1007/s00330022-09382-2 15 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Chen, Z. T., Li, X. L., Jin, F. S., Shi, Y. L., Zhang, L., Yin, H. H., Zhu, Y. L., Tang, X. Y., Lin, X. Y., Lu, B. L., Wang, Q., Sun, L. P., Zhu, X. X., Qiu, L., Xu, H. X., & Guo, L. H. (2025). Diagnosis of Sarcopenia Using Convolutional Neural Network Models Based on Muscle Ultrasound Images: Prospective Multicenter Study. Journal of medical Internet research, 27, e70545. https://doi.org/10.2196/70545 Chiu, C. H., Chen, J. F., Yu, S. F., Hsu, C. Y., Chen, Y. C. (2025). Decreased quadriceps muscle stiffness on ultrasound elastography is associated with sarcopenia in end-stage kidney disease. Frontiers in nephrology, 5, 1682826. https://doi.org/10.3389/fneph.2025.1682826 Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., Bautmans, I., Baeyens, J. P., Cesari, M., … Schols, J. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16-31. https://doi.org/10.1093/ageing/afy169 De La Flor, J. C., García-Menéndez, E., Romero-González, G., Rodríguez Tudero, C., Jiménez Mayor, E., Florit Mengual, E., Moral Berrio, E., Soria Morales, B., Cieza Terrones, M., Cigarrán Guldris, S., & Hernández Vaquero, J. (2025). Morphofunctional Assessment of Malnutrition and Sarcopenia Using Nutritional Ultrasonography in Patients Undergoing Maintenance Hemodialysis. Medicina (Kaunas, Lithuania), 61(6), 1044. https://doi.org/10.3390/medicina61061044 de la Torre, J., Arnau, A., Singla, A., Iriarte, M., Galceran, J. M., Díaz, J. M., & Esteve-Simó, V. (2026). Diagnostic Accuracy of Rectus Femoris Ultrasound for Identifying Sarcopenia as Defined by the European Working Group on Sarcopenia in Older People 2 in Haemodialysis Patients. Diagnostics (Basel, Switzerland), 16(16), 2490. https://doi.org/10.3390/diagnostics16162490 de Luis Roman, D., García Almeida, J. M., Bellido Guerrero, D., Guzmán Rolo, G., Martín, A., Primo Martín, D., García-Delgado, Y., Guirado-Peláez, P., Palmas, F., Tejera Pérez, C., García Olivares, M., Maíz Jiménez, M., Bretón Lesmes, I., Alzás Teomiro, C. M., Guardia Baena, J. M., Calles Romero, L. A., Prior-Sánchez, I., García-Luna, P. P., González Pacheco, M., … Olveira, G. (2024). Ultrasound Cut-Off Values for Rectus Femoris for Detecting Sarcopenia in Patients with Nutritional Risk. Nutrients, 16(11), 1552. https://doi.org/10.3390/nu16111552 Deng, M., Zhou, X., Li, Y., Yin, Y., Liang, C., Zhang, Q., Lu, J., Wang, M., Wang, Y., Sun, Y., Li, R., Yan, L., Wang, Q., & Hou, G. (2021). Ultrasonic Elastography of the Rectus Femoris, a Potential Tool to Predict Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease. Frontiers in physiology, 12, 783421. https://doi.org/10.3389/fphys.2021.783421 Dong, Z., Chen, J., Ge, J., Zhao, M., Zhao, Y., Zheng, S., Ye, J., Sun, X., Huang, B. (2025). Respiratory and peripheral muscle ultrasound, including shear-wave elastography, for sarcopenia screening in COPD. Frontiers in nutrition, 12, 1687103. https://doi.org/10.3389/fnut.2025.1687103 Fernández-Jiménez, R., Cabrera-Cesar, E., Sanmartín-Sánchez, A., Sánchez-Garcia, A., Espildora-Hernandez, F., Vegas-Aguilar, I., Del Mar Amaya-Campos, M., Guirado-Pelaez, P., Simón-Frapolli, V., Murri, M., Garrido-Sánchez, L., Piñel-Jimenez, L., Cano-Gamonoso, M. B., López-García, J., Gómez-Rodríguez, B., Velasco-Garrido, J. L., Tinahones, F. J., & García-Almeida, J. M. (2024). Rectus femoris cross sectional area and timed up and go test potential useful of as a predictor of sarcopenia and mortality in idiopathic pulmonary fibrosis. Frontiers in nutrition, 11, 1440402. https://doi.org/10.3389/fnut.2024.1440402 Fu, H., Luo, S., Zhuo, Y., Lian, R., Chen, X., Jiang, W., Wang, L., Yang, M. (2025). Enhanced Sarcopenia Detection in Nursing Home Residents Using Ultrasound Radiomics and Machine Learning. Journal of the American Medical Directors Association, 26(11), 105830. https://doi.org/10.1016/j.jamda.2025.105830 Fu, H., Wang, L., Zhang, W., Lu, J., & Yang, M. (2023). Diagnostic test accuracy of ultrasound for sarcopenia diagnosis: A systematic review and meta‐analysis. Journal of Cachexia, Sarcopenia and Muscle, 14(1), 57-70. https://doi.org/10.1002/jcsm.13149 Fukuda, T., Yokomachi, J., Yamaguchi, S., Yagi, H., Shibasaki, I., Ugata, Y., Sakuma, M., Yasuda, T., Abe, S., Fukuda, H., Fujita, H., Toyoda, S., & Nakajima, T. (2024). CAN WE DIAGNOSE SARCOPENIA USING ANTERIOR FEMORAL MUSCLE THICKNESS IN PATIENTS WITH CARDIOVASCULAR DISEASE?. Journal of rehabilitation medicine. Clinical communications, 7, 12378. https://doi.org/10.2340/jrmcc.v7.12378 Güner, M., Girgin, S., Ceylan, S., Özcan, B., Öztürk, Y., Okyar Baş, A., Koca, M., Balcı, C., Doğu, B. B., Cankurtaran, M., Yıldırım, T., Halil, M. (2024). The Role of Muscle Ultrasonography to Diagnose Malnutrition and Sarcopenia in Maintenance Hemodialysis. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 34(4), 330-336. https://doi.org/10.1053/j.jrn.2023.12.001 Guo, L., Ran, L., Zhang, Y., Guo, X., Li, J., Gong, Y., Zhou, X., & Wu, X. (2023). Evaluation of muscle elasticity in patients with end-stage renal disease complicated with sarcopenia by real-time shear wave elastography multipoint measurement. Revista Romana de Medicina de Laborator, 31(2), 135-144. https://doi.org/10.2478/rrlm-2023-0008 Han, X., Li, Q., Zhang, G., & Zhang, Z. (2025). Application value of two-dimensional ultrasound and shear-wave elastography parameters in evaluating sarcopenia with essential hypertension. Quantitative imaging in medicine and surgery, 15(1), 831-842. https://doi.org/10.21037/qims-24-1718 Kılıç, Z., Yurdakul, F. G., Güler, T., Nakipoğlu Yüzer, G. F., & Bodur, H. (2026). Sarcopenia-Related Factors and the Diagnostic Role of Ultrasonography in Rheumatoid Arthritis. Archives of Rheumatology. https://doi.org/10.5152/archrheumatol.2026.26339 Kuyumcu, M. E., Halil, M., Kara, Ö., Çuni, B., Çağlayan, G., Güven, S., Yeşil, Y., Arık, G., Yavuz, B. B., Cankurtaran, M., Özçakar, L. (2016). Ultrasonographic evaluation of the calf muscle mass and architecture in elderly patients with and without sarcopenia. Archives of gerontology and geriatrics, 65, 218-24. https://doi.org/10.1016/j.archger.2016.04.004 Lee, B. C., Lee, J., Cho, K. H., & Moon, C. (2026). Identification of ultrasound predictors and development of a diagnostic scoring system for sarcopenia using LASSO regression: a cross-sectional study. Scientific reports, 16(1), 17116. https://doi.org/10.1038/s41598-026-47400-1 Li, S., Li, H., Hu, Y., Zhu, S., Xu, Z., Zhang, Q., Yang, Y., Wang, Z., & Xu, J. (2020). Ultrasound for Measuring the Cross-Sectional Area of Biceps Brachii Muscle in Sarcopenia. International journal of medical sciences, 17(18), 2947-2953. https://doi.org/10.7150/ijms.49637 Lim, L. S., Lu, C. H., Lai, Y. R., Kan, N. N., Liao, C. C., & Lee, S. Y. (2025). Muscle Ultrasonography as a Diagnostic Tool for Assessing Sarcopenia in Parkinson's Disease. Journal of movement disorders, 18(4), 347-354. https://doi.org/10.14802/jmd.25072 16 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Liu, T., Wan, J., Liu, Y., Zhuo, J., & Fu, W. (2025). Value of ultrasound assessment of sarcopenia in patients with diffuse large B-cell lymphoma: a prospective study. Radiology and oncology, 59(3), 301-310. https://doi.org/10.2478/raon-2025-0036 López-Gómez, J. J., Sánchez-Lite, I., Fernández-Velasco, P., Izaola-Jauregui, O., Cebriá, Á., Pérez-López, P., González-Gutiérrez, J., Estévez-Asensio, L., Primo-Martín, D., Gómez-Hoyos, E., Jorge-Godoy, E., & De Luis-Román, D. A. (2025). Artificial intelligence-assisted rectus femoris ultrasound vs. L3 computed tomography for sarcopenia assessment in oncology patients: establishing diagnostic cut-offs for muscle mass and quality. Frontiers in nutrition, 12, 1678989. https://doi.org/10.3389/fnut.2025.1678989 McInnes, M. D. F., Moher, D., Thombs, B. D., McGrath, T. A., Bossuyt, P. M., Clifford, T., Cohen, J. F., Deeks, J. J., Gatsonis, C., Hooft, L., Hunt, H. A., Hyde, C. J., Korevaar, D. A., Leeflang, M. M. G., Macaskill, P., Reitsma, J. B., Rodin, R., Rutjes, A. W. S., Salameh, J. P., … Willis, B. H. (2018). Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies. JAMA, 319(4), 388. https://doi.org/10.1001/jama.2017.19163 Mondo, L., Louis, C., Saboul, H., Beernaert, L., & De Breucker, S. (2025). Diagnostic Value of Point-of-Care Ultrasound for Sarcopenia in Geriatric Patients Hospitalized for Hip Fracture. Journal of clinical medicine, 14(15), 5424. https://doi.org/10.3390/jcm14155424 Nijholt, W., Scafoglieri, A., Jager-Wittenaar, H., Hobbelen, J. S. M., & van der Schans, C. P. (2017). The reliability and validity of ultrasound to quantify muscles in older adults: A systematic review. Journal of Cachexia, Sarcopenia and Muscle, 8(5), 702–712. https://doi.org/10.1002/jcsm.12210 Ozturk, Y., Koca, M., Burkuk, S., Unsal, P., Dikmeer, A., Oytun, M. G., Bas, A. O., Kahyaoglu, Z., Deniz, O., Coteli, S., Ileri, I., Dogu, B. B., Cankurtaran, M., Halil, M. (2022). The role of muscle ultrasound to predict sarcopenia. Nutrition (Burbank, Los Angeles County, Calif.), 101, 111692. https://doi.org/10.1016/j.nut.2022.111692 Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, n71. https://doi.org/10.1136/bmj.n71 Pereira, A. S., Shitsuka, D. M., Parreira, https://repositorio.ufsm.br/handle/1/15824 F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. Editora UFSM. Perkisas, S., Bastijns, S., Baudry, S., Bauer, J., Beaudart, C., Beckwée, D., Cruz-Jentoft, A. J., Gasowski, J., Hobbelen, H., Jager-Wittenaar, H., Kasiukiewicz, A., Landi, F., Małek, M., Marco, E., Martone, A. M., de Miguel, A. M., Piotrowicz, K., Sánchez, E., Scafoglieri, A., et al. (2021). Application of ultrasound for muscle assessment in sarcopenia: 2020 SARCUS update. European Geriatric Medicine, 12(1), 45–59. https://doi.org/10.1007/s41999-020-00433-9 Pus, K., Sarto, F., Narici, M., & Šimunič, B. T. (2026). The application of ultrasound sarcopenia index in sarcopenic population. Experimental gerontology, 217, 113109. https://doi.org/10.1016/j.exger.2026.113109 Qin, K., Chen, W., Qi, H., Wang, T., Wang, Y., Zhang, H., & Teng, J. (2025). Value of grayscale histogram analysis based on ultrasound images in diagnosing sarcopenia. Quantitative imaging in medicine and surgery, 15(9), 7885-7895. https://doi.org/10.21037/qims-2025-638 Risemberg, R. I. C., Wakin, M., & Shitsuka, R. (2026a). A importância da metodologia científica no desenvolvimento de artigos científicos. E-Acadêmica, 7(1), e0171675. https://doi.org/10.52076/eacad-v7i1.675 Risemberg, R. I. C., Wakin, M., & Shitsuka, R. (2026b). Qualitativa, quantitativa ou quali-quantitativa: Como identificar de modo rápido a abordagem de um artigo científico? E-Acadêmica, 7(2), e0172702. https://doi.org/10.52076/eacad-v7i2.702 Rustani, K., Kundisova, L., Capecchi, P. L., Nante, N., Bicchi, M. (2019). Ultrasound measurement of rectus femoris muscle thickness as a quick screening test for sarcopenia assessment. Archives of gerontology and geriatrics, 83, 151-154. https://doi.org/10.1016/j.archger.2019.03.021 Sato, Y., Shiraishi, H., Nakanishi, N., Zen, K., Nakamura, T., Yamano, T., Shirayama, T., Matoba, S. (2020). Clinical significance of rectus femoris diameter in heart failure patients. Heart and vessels, 35(5), 672-680. https://doi.org/10.1007/s00380-019-01534-7 Shou, J., Ouyang, C., Lin, J., Huang, J., Yang, H., & He, Y. (2025). Value of Conventional Ultrasound Combined with Shear Wave Elastography for Sarcopenia in Patients with Cardiovascular Disease. Clinical interventions in aging, 20, 2627-2639. https://doi.org/10.2147/CIA.S553232 Sri-On, J., Rueanthip, S., Vanichkulbodee, A., Paksopis, T., & Chetanasilpin, C. (2022). The Validity of Ultrasonographic Measurements of the Rectus Femoris Muscle in Older Adults with Sarcopenia in Thai Population. Clinical interventions in aging, 17, 1249-1259. https://doi.org/10.2147/CIA.S375419 Tada, M., Yamada, Y., Mandai, K., & Hidaka, N. (2021). Screening for sarcopenia and obesity by measuring thigh muscle and fat thickness by ultrasound in patients with rheumatoid arthritis. Osteoporosis and sarcopenia, 7(2), 81-87. https://doi.org/10.1016/j.afos.2021.06.002 Tang, X., Huang, S., Huang, L., Feng, Z., Wang, Z., Yue, J., & Qiu, L. (2022). Ultrasound-derived muscle assessment system for older adults: a promising muscle mass estimation tool. Age and ageing, 51(12), afac298. https://doi.org/10.1093/ageing/afac298 University of Bristol (2024). QUADAS-3: A revised tool for the quality assessment of diagnostic accuracy studies. QUADAS website. https://www.bristol.ac.uk/population-health-sciences/projects/quadas/quadas-3/ Wang, S., Lu, X., Chen, J., Xu, X., Jiang, J., & Dong, Y. (2025). Predicting Sarcopenia in Peritoneal Dialysis Patients: A Multimodal Ultrasound-Based Logistic Regression Analysis and Nomogram Model. Diagnostics (Basel, Switzerland), 15(21), 2685. https://doi.org/10.3390/diagnostics15212685 Wang, Y., Hu, Y., Liu, Y., Ji, M., Sun, R., Yang, S., & Wu, J. (2026). Development and Validation of a Nomogram Combining Ultrasound Parameters and Clinical Indicators for Predicting Sarcopenia in Breast Cancer Patients. [Preprint]. Research Square. https://doi.org/10.21203/rs.3.rs-8599311/v1 Wang, Z., Lyu, G., Zhong, H., Yan, L., Xu, Z. (2023). Shear Wave Elastography for Detecting Calf Muscle Stiffness: An Effective Tool for Assessing Sarcopenia. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 42(4), 891-900. https://doi.org/10.1002/jum.16082 17 Research, Society and Development, v. 15, n. 10, e24151051768, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i10.51768 Wei, A., Zou, Y., Tang, Z. H., Guo, F., & Zhou, Y. (2025). A sarcopenia prediction model based on the calf maximum muscle circumference measured by ultrasound. BMC geriatrics, 25(1), 81. https://doi.org/10.1186/s12877-025-05733-y Yang, F., Zhu, L., Cao, B., Zeng, L., Yuan, Z., Tian, Y., Li, Y., & Chen, X. (2025). Accuracy of Ultrasound Measurements of Muscle Thickness in Identifying Older Patients With Sarcopenia and Its Impact on Frailty: A Systematic Review and Meta-Analysis. Journal of the American Medical Directors Association, 26(2), 105419. https://doi.org/10.1016/j.jamda.2024.105419 Yang, Q., Zhang, C., Zhang, Z., & Su, B. (2024). Muscle ultrasound to diagnose sarcopenia in chronic kidney disease: a systematic review and bayesian bivariate meta-analysis. BMC Nephrology, 25(1), 12. https://doi.org/10.1186/s12882-023-03445-2 Yik, V., Kok, S. S. X., Chean, E., Lam, Y. E., Chua, W. T., Tan, W. J., Foo, F. J., Ng, J. L., Su, S. S., Chong, C. X. Z., Aw, D. K. L., Khoo, N. A. X., Wischmeyer, P. E., Molinger, J., Wong, S., Ong, L. W. L., & Koh, F. H. X. (2024). Diagnosing Sarcopenia with AI-Aided Ultrasound (DINOSAUR)-A Pilot Study. Nutrients, 16(16), 2768. https://doi.org/10.3390/nu16162768 Yoshida, T., Watanabe, Y., Yokoyama, K., Kimura, M., Yamada, Y. (2024). Thigh muscle thickness on ultrasonography for diagnosing sarcopenia: The KyotoKameoka study. Geriatrics & gerontology international, 24 Suppl 1, 156-161. https://doi.org/10.1111/ggi.14714 Zanotelli, A., Rossi, A. P., Del Monte, L., Vantini, G., Stabile, G., Urbani, S., Giani, A., Zoico, E., Babbanini, A., Fantin, F., Zamboni, M., & Mazzali, G. (2024). The Role of Combined Muscle Ultrasound and Bioimpedentiometry Parameters for Sarcopenia Diagnosis in a Population of Hospitalized Older Adults. Nutrients, 16(15), 2429. https://doi.org/10.3390/nu16152429 Zehnder, R., Schimmel, M., Meyer, L., Kömeda, M., Limacher, A., & Eggimann, A. K. (2025). Discriminative Ability and Associations of Sarcopenia Using Point-of-Care Ultrasound with Functional, Mobility and Frailty Status in Older Inpatients. Journal of clinical medicine, 14(5), 1603. https://doi.org/10.3390/jcm14051603 Zhang, X. Y., Yang, Y. (2024). The value of multi-modal ultrasound in the assessment of sarcopenia in maintenance hemodialysis patients. Revista clinica espanola, 224(7), 437-444. https://doi.org/10.1016/j.rceng.2024.06.003 Zhao, P., Ding, C., Zhang, Y., Wu, J., Yang, M., Wang, C., & Liu, C. (2026). Evaluation of Muscle Stiffness in Patients with Parkinson’s Disease with Different Stages of Sarcopenia by Shear Wave Elastography. Journal of Medical and Biological Engineering, 46(1), 38-49. https://doi.org/10.1007/s40846-026-01005-1 18